AMH low for age — what it means about ovarian reserve
Anti-Müllerian hormone (AMH) is produced by granulosa cells of small ovarian follicles and reflects the size of the remaining follicle pool — i.e., 'ovarian reserve.' AMH declines steadily through reproductive life (peak ~25, near-zero at menopause) and a low AMH for your age range indicates diminished ovarian reserve relative to peers — meaning fewer eggs available for natural conception or IVF stimulation. AMH is the most stable marker of ovarian reserve (cycle-day independent, unlike FSH or oestradiol) and is the dominant predictor used in fertility clinics for IVF response prediction.
Reference ranges
| Reproductive peak (25-30 yrs) | 2.0 – 6.8 ng/mL (15 – 49 pmol/L) |
| Age 30-35 | 1.5 – 4.0 ng/mL |
| Age 35-40 | 1.0 – 3.0 ng/mL |
| Age 40-45 | 0.5 – 1.5 ng/mL |
| Diminished reserve threshold | < 1.0 ng/mL |
| Premature ovarian insufficiency | < 0.16 ng/mL |
What this marker measures
AMH is produced by granulosa cells of pre-antral and small antral ovarian follicles. Because each follicle's AMH output is finite and the total AMH reflects the number of follicles, serum AMH is a direct quantitative readout of remaining follicle count. Unlike FSH (which fluctuates day-to-day and only rises late in reserve depletion), AMH falls smoothly across reproductive life and can be measured on any cycle day with a standard immunoassay.
Why might it be low?
- ·Age-related decline (the dominant factor)
- ·Premature ovarian insufficiency (POI) — autoimmune, genetic, or idiopathic
- ·Prior ovarian surgery (cyst removal, endometriosis surgery)
- ·Chemotherapy or pelvic radiation
- ·Smoking (accelerates ovarian ageing)
- ·BRCA1/2 mutations (associated with earlier reserve decline)
- ·Hormonal contraceptive use (transiently suppresses AMH ~25%)
Why might it be elevated?
- ·Polycystic ovary syndrome (PCOS) — many small follicles produce high AMH
- ·Granulosa cell tumours (rare)
- ·Recent ovarian stimulation
FAQ
Does low AMH mean I can't conceive?+
Not necessarily. AMH reflects follicle quantity, not quality — a woman with low AMH can still ovulate fertile eggs. It does mean the window is narrower (fewer eggs total over time, less response to IVF stimulation). Direct natural-conception predictive value is moderate; IVF response predictive value is high.
Can lifestyle improve AMH?+
Limited literature support. Smoking cessation, vitamin D correction (where deficient), DHEA supplementation in select cases (controversial), and CoQ10 / mitochondrial support have small to modest associations in some research. The dominant determinant remains chronological age.
This page describes biomarker research and reference ranges for self-tracking and research-context discussion only. It is not medical advice, not a diagnosis, and not a substitute for a qualified physician. Take any concerns about your health to a clinician.
Have your own panel? Read it next to the standard reference ranges with our free analyse tool.
Analyse my blood work →- BiomarkerDHEA-S 80 µg/dL
Dehydroepiandrosterone sulphate at 80 µg/dL in a man in his 40s is below the typical age-matched range. What DHEA-S measures, why the literature treats it as a global endocrine marker, and what its decline means.
- BiomarkerTotal T 450 ng/dL
Total testosterone of 450 ng/dL in a 35-year-old man is technically inside the standard reference range but well below the age-matched mean. What the number means without free T and SHBG context — and what a deeper read tells you.
- BiomarkerSHBG low (male)
Sex hormone binding globulin below the male reference range is a strong signal of insulin resistance and metabolic syndrome — and it makes total testosterone readings deeply misleading. What the literature says.
- ResearchIpamorelin 10 mg
Ipamorelin is a selective ghrelin-receptor (GHSR) agonist. One of the cleanest pharmacological profiles in the growth-hormone-secretagogue class.
- ResearchCJC-1295 with DAC 5 mg
CJC-1295 with Drug Affinity Complex (DAC) — an extended GHRH analogue designed for half-life extension through covalent albumin binding.
- ResearchCJC-1295 no DAC 10 mg
CJC-1295 without DAC — short-acting modified GRF(1-29). Commonly used in preclinical GH-pulse research alongside ipamorelin.